WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations
The product will be manufactured at Lupin’s facility in Pithampur, India
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
Divalproex Sodium Extended-Release tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
To be marketed by Strides Pharma Inc. in the US market
Resolv ER may remedy leading causes of blindness in adults
Subscribe To Our Newsletter & Stay Updated
